Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy

Therapeutic Drug Monitoring

Volumn 28, Issue 5, 2006, Pages 608-613

  Vethe, Nils Tore ^b   Bergan, Stein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

Immunosuppression; IMPDH; Inosine monophosphate dehydrogenase; Mycophenolic acid; Pharmacodynamics

Indexed keywords

ANTIBODY; CD4 ANTIGEN; DEOXYGUANOSINE PHOSPHATE; GUANINE NUCLEOTIDE; INOSINATE DEHYDROGENASE; INOSINE PHOSPHATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; XANTHINE; XANTHOSINE; XANTHOSINE 5 PHOSPHATE;

ARTICLE; BLOOD VOLUME; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CELL ISOLATION; CELL LYSATE; CELL PROLIFERATION; CHEMICAL REACTION KINETICS; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYDROLYSIS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; LIQUID CHROMATOGRAPHY; MICROFILTRATION; NORMAL HUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; RELIABILITY; SINGLE DRUG DOSE;

ANTIGENS, CD4; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; MYCOPHENOLIC ACID;

EID: 33749873377     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000245680.38143.ca     Document Type: Article

References (19)

1. Zimmermann AG, Gu JJ, Laliberte J, et al. Inosine-5′-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol. 1998;61:181-209.
2. Nagai M, Natsumeda Y, Konno Y, et al. Selective up-regulation of type-II inosine 5′-monophosphate dehydrogenase messenger-RNA expression in human leukemias. Cancer Res. 1991;51:3886-3890.
3. Franklin TJ, Cook JM. Inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J. 1969;113:515-524.
4. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47:85-118.
5. Halloran P, Mathew T, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation. 1997;63:39-47.
6. van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation. 1999;68:261-266.
7. Kiberd BA, Lawen J, Fraser AD, et al. Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant. 2004;4:1079-1083.
8. Premaud A, Le Meur Y, Debord J, et al. Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods. Ther Drug Monit. 2005;27:354-361.
9. Ikegami T, Natsumeda Y, Weber G. Direct assay-method for inosine 5′-monophosphate dehydrogenase-activity. Anal Biochem. 1985;150:155-160.
10. Proffitt RT, Pathak VK, Villacorte DG, et al. Sensitive radiochemical assay for inosine 5′-monophosphate dehydrogenase and determination of activity in murine tumor and tissue-extracts. Cancer Res. 1983;43:1620-1623.
11. Balzarini J, Declercq E. Assay-method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes. Biochem J. 1992;287:785-790.
12. Cooney DA, Wilson Y, Mcgee E. A straightforward radiometric technique for measuring IMP dehydrogenase. Anal Biochem. 1983;130:339-345.
13. Albrecht W, Storck M, Pfetsch E, et al. Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5′-monophosphate dehydrogenase in whole blood and isolated mononuclear cells. Ther Drug Monit. 2000;22:283-294.
14. Daxecker H, Raab M, Muller MM. Influence of mycophenolic acid on inosine 5′-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells. Clin Chim Acta. 2002;318:71-77.
15. Glander P, Braun KP, Hambach P, et al. Non-radioactive determination of inosine 5′-monophosphate dehydrogenase (IMPDH) in peripheral mononuclear cells. Clin Biochem. 2001;34:543-549.
16. Griesmacher A, Weigel G, Seebacher G, et al. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clin Chem. 1997;43:2312-2317.
17. Montero C, Duley JA, Fairbanks LD, et al. Demonstration of induction of erythrocyte inosine monophosphate dehydrogenase-activity in ribavirin-treated patients using a high-performance liquid-chromatography linked method. Clin Chim Acta. 1995;238:169-178.
18. Svensson JO, Brattstrom C, Sawe J. A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma. Ther Drug Monit. 1999;21:322-324.
19. Mandla R, Line PD, Midtvedt K, et al. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit. 2003;25:407-414.